Venous Leg Ulcer Clinical Trial
— SNAKOfficial title:
A Nurse-led Intervention Consisting of a Structured Dialogue, Patient and Relative Information, and Protein Supplement for Patients With Leg Ulcers in Clinical Practice: A Feasibility Study
The objective of this study is to examine the feasibility, acceptability, fidelity, and outcome of a nurse-led nutritional intervention for patients with leg ulcers in a outpatient clinics. The intervention consists of a structured dialogue and patient information on key lifestyle behaviours to improve wound healing. Furthermore, the intervention includes protein supplement.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | December 31, 2024 |
Est. primary completion date | May 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with leg ulcers caused by arterial or venous disease or neuropathy caused by diabetes. - Patient with an amputation wound. - Speak and understand Danish. Exclusion Criteria: - Patients with wounds caused by high-intensity trauma. - Patients in the end-of-life phase. - Patients living in nursing homes. - Patients with cognitive impairment. |
Country | Name | City | State |
---|---|---|---|
Denmark | Outpatient clinic at the Department of Orthopedic Surgery, Hvidovre University Hospital | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Hvidovre University Hospital | Roskilde University |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | SNAK Feasibility questionnaire (SFQ) - Element 1: Evaluating structured dialogue | The intervention is deemed non-feasible if, during their visit to the outpatient clinic, fewer than 80% of the patients:
Noticed the dialogue tool. Had a conversation with the nurses about nutrition and wound healing using the dialogue tool. Found the conversation with the nurses about nutrition and wound healing relevant and valuable. Considered it acceptable to have a conversation with the nurses about nutrition and wound healing. The SFQ has two scoring systems: 1) Binary scores (yes/no) with a non-applicable option as well and 2) categorical 5-point score (1 is the highest score and 5 is the lowest score in regards to agreement on statements related to the interventions feasibility). The 5-point categorical score will be presented with median and interquartile ranges (IQR). |
Measurements will be taken within 1 week after their second and third visits to the outpatient clinic. Each patient will be followed up to maximum 16 weeks after inclusion. | |
Primary | SNAK Feasibility questionnaire (SFQ) - Element 2: Evaluating patient and relative information | The intervention is considered non-feasible if, during their visit to the outpatient clinic, fewer than 80% of the patients:
Received a leaflet. Could read and understand the leaflet. Found the information in the leaflet relevant. have attempted to use the suggested recipes or food categories. have attempted to change their diet. The SFQ has two scoring systems: 1) Binary scores (yes/no) with a non-applicable option as well and 2) categorical 5-point score (1 is the highest score and 5 is the lowest score in regards to agreement on statements related to the interventions feasibility). The 5-point categorical score will be presented with median and interquartile ranges (IQR). |
Measurements will be taken within 1 week after their second and third visits to the outpatient clinic. Each patient will be followed up to maximum 16 weeks after inclusion. | |
Primary | SNAK Feasibility questionnaire (SFQ) - Element 3: Evaluating protein supplement | The intervention is considered non-feasible if, during their visit to the outpatient clinic, fewer than 80% of the patients:
Were offered a protein supplement drink. Were offered a prescription for protein supplement drinks. Agree that patients should be offered a protein supplement drink. The SFQ has two scoring systems: 1) Binary scores (yes/no) with a non-applicable option as well and 2) categorical 5-point score (1 is the highest score and 5 is the lowest score in regards to agreement on statements related to the interventions feasibility). The 5-point categorical score will be presented with median and interquartile ranges (IQR). |
Measurements will be taken within 1 week after their second and third visits to the outpatient clinic. Each patient will be followed up to maximum 16 weeks after inclusion. | |
Primary | SNAK Feasibility questionnaire (SFQ) - Element 4: Evaluating overall intervention | The intervention is considered non-feasible if fewer than 80% of the patients, during their visit to the outpatient clinic, are confident that they can follow the advice regarding nutrition and lifestyle in their daily lives.
The SFQ has two scoring systems: 1) Binary scores (yes/no) with a non-applicable option as well and 2) categorical 5-point score (1 is the highest score and 5 is the lowest score in regards to agreement on statements related to the interventions feasibility). The 5-point categorical score will be presented with median and interquartile ranges (IQR). |
Measurements will be taken within 1 week after their second and third visits to the outpatient clinic. Each patient will be followed up to maximum 16 weeks after inclusion. | |
Primary | Qualitative evaluation of nurses' Capability, Opportunity, and Motivation (COM-B) to implement the intervention. | COM-B will be explored using a semi-structured focus group interview with the nurses and will be carried out in the outpatient clinic following the end of inclusion (16 weeks after first inclusion). | Measured 16 weeks after first inclusion. | |
Primary | Procedural uncertainties - Number of patients willing to participate. | Following criteria are considered to evaluate the recruitment of participation in the intervention.
If less than 30% are willing to participate in the intervention, then the intervention is considered non-feasible. If recruitment falls within the range of 30 to 80% modification will be considered. If 80% or more are recruited, the study is deemed feasible without modification. |
Measured 4, 8, 12, and 16 weeks after first inclusion. | |
Secondary | Recruitment rates | The number of eligible patients that agree to participate will be collected. | Every week until study completion (16 weeks after first inclusion). | |
Secondary | Drop out rates | The number of included patients that withdraw consent or drop out for other reasons will be collected. Furthermore, we will collect reasons for dropout. | Every week until study completion (16 weeks after first inclusion). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03903692 -
A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers
|
N/A | |
Completed |
NCT03257254 -
Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
|
||
Recruiting |
NCT03666754 -
Early Glue Saphenous Vein Ablation With Compression Versus Compression Alone in the Healing of the Venous Ulcer
|
N/A | |
Withdrawn |
NCT02912858 -
Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer Patients
|
N/A | |
Completed |
NCT02482038 -
Geko Venous Leg Ulcer Study
|
N/A | |
Completed |
NCT02652572 -
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
|
Phase 1 | |
Unknown status |
NCT01658618 -
Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer
|
N/A | |
Completed |
NCT05646121 -
Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
|
||
Completed |
NCT03077165 -
Dose-response Relationship Study of S42909 on Leg Ulcer Healing
|
Phase 2 | |
Completed |
NCT04461132 -
The Effect of Manual Lymphatic Drainage
|
N/A | |
Completed |
NCT05974982 -
Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers
|
Phase 1 | |
Completed |
NCT04011371 -
Cyanoacrylate Closure for Treatment of Venous Leg Ulcers
|
N/A | |
Not yet recruiting |
NCT03543007 -
Evaluating the Safety and Efficacy of GrafixPLâ„¢PRIME for the Treatment of Chronic Venous Leg Ulcers
|
N/A | |
Completed |
NCT03286140 -
Early Venous Reflux Ablation Ulcer Trial
|
N/A | |
Recruiting |
NCT05588583 -
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
|
N/A | |
Not yet recruiting |
NCT04613687 -
Efficacy and Safety of a New Compression System URGO BD001 in the Treatment of VLU (FREEDOM)
|
N/A | |
Recruiting |
NCT05549609 -
A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers
|
Phase 1/Phase 2 | |
Recruiting |
NCT05409976 -
The GORE® VIAFORT Vascular Stent IVC Study
|
N/A | |
Not yet recruiting |
NCT05089890 -
Clinical Investigation of Sorbact® Dressings
|
N/A | |
Not yet recruiting |
NCT03670329 -
Management of Infection Risk in Non-comparative Trial (MINT)
|
N/A |